Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

China · Delayed Price · Currency is CNY

18.50

-0.14 (-0.75%)

Jul 22, 2026, 3:00 PM CST

-36.77% (1Y)

Market Cap	3.60B -35.2%
Revenue (ttm)	1.01B +20.9%
Net Income	-551.99M
EPS	-2.91
Shares Out	193.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,506,577
Open	18.81
Previous Close	18.64
Day's Range	18.36 - 18.96
52-Week Range	17.03 - 30.65
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:688298

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagn... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2005

Employees 2,283

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688298

Full Company Profile

Financial Performance

In 2025, SHA:688298's revenue was 947.38 million, an increase of 14.43% compared to the previous year's 827.92 million. Losses were -573.60 million, 8.43% more than in 2024.

Financial Statements